Rare Diseases
Daily News
Stay up to date with the latest clinical headlines.
Thank you for signing up for the Daily News alerts. You will begin receiving them shortly.
October 24, 2024
New Hope for Patients With HER2-Mutant NSCLC: Durable Responses to Two Novel Targeted Therapies
The ASCO Post
October 17, 2024
Addition of Thoracic Radiotherapy to First-Line Treatment of EGFR-Mutated Metastatic NSCLC
The ASCO Post
October 16, 2024
Tumor Treating Fields Therapy Receives FDA Approval in Metastatic NSCLC
The ASCO Post
Advertisement
Recommendations
Advertisement